Irena Glumac

Irena Marjanović

Istraživač saradnik
Laboratorija za molekularnu biomedicinu

Institut za molekularnu genetiku i genetičko inženjerstvo (IMGGI),
Univerzitet u Beogradu,

V. Stepe 444a, 11010 Beograd, Srbija
Mob:   +381 65 3976 445
Tel:     +381 11 3976 445
Fax:    +381 11 397 58 08
E-mail: irena.glumac@imgge.bg.ac.rs                          

OBRAZOVANJE

2018 - doktor bioloških nauka, Biološki fakultet (BF), Univerzitet u Beogradu (UB),
(naslov teze: "Identifikacija molekularno-genetičkih markera patogeneze akutne mijeloidne leukemije")
2011 - Doktorske studije. Modul - molekularna biologija eukariota, FB, Univerzitet u Beogradu
2010 - Diplomirani molekularni biolog i fiziolog, FB, Univerzitet u Beogradu

ISTRAŽIVAČKO ISKUSTVO

2013 - istraživač saradnik, IMGGI, UB
2012 - 2013 - istraživač pripravnik, Institut za molekularnu genetiku i genetičko inženjerstvo, (IMGGI), UB

OBLAST NAUČNOG INTERESOVANJA

Akutna i hronična mijeloidna leukemija. Multipli mijelom. Genetička osnova i poremećaj procesa diferencijacije, proliferacije i apoptoze. Molekularni markeri značajni za dijagnozu bolesti, praćenje i terapiju ovih hematoloških maligniteta.

ODABRANI NAUČNI RADOVI

  1. Todorovic Balint, Jelicic J, Mihaljevic B, Kostic J, Stanic B, Balint B, Pejanovic N, Lucic B, Tosic N, Marjanovic I, Stojiljkovic M, Karan-Djurasevic T, Perisic O, Rakocevic G, Popovic M, Raicevic S, Bila J, Antic D, Andjelic B, Pavlovic S. “Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses.” Int J Mol Sci. 2016 May 6;17(5).
  2. Marjanovic I, Karan-Djurasevic T, Ugrin M, Virijevic M, Vidovic A, Tomin D, Suvajdzic Vukovic N, Pavlovic S, Tosic N. “Use of Wilms Tumor 1 Gene Expression as a Reliable Marker for Prognosis and Minimal Residual Disease Monitoring in Acute Myeloid Leukemia With Normal Karyotype Patients.“  Clin Lymphoma Myeloma Leuk. 2017 May;17(5):312-319.
  3. Marjanovic I, Kostic J, Stanic B, Pejanovic N, Lucic B, Karan-Djurasevic T, Janic D, Dokmanovic L, Jankovic S, Vukovic NS, Tomin D, Perisic O, Rakocevic G5, Popovic M, Pavlovic S, Tosic N. „Parallel targeted next generation sequencing of childhood and adult acute myeloid leukemia patients reveals uniform genomic profile of the disease.“ Tumor Biol. 2016 Oct;37(10):13391-13401.
  4. Virijevic M, Karan-Djurasevic T, Marjanovic I, Tosic N, Mitrovic M, Djunic I, Colovic N, Vidovic A, Suvajdzic-Vukovic N, Tomin D, Pavlovic S. “Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukaemia with normal karyotype.” Radiol Oncol. 2016 Sep 8;50(4):385-393.
  5. Bila J, Sretenovic A, Jelicic J, Tosic N, Glumac I, Fekete MD, Antic D, Balint MT, Markovic O, Milojevic Z, Radojkovic M, Trajkovic G, Puric M, Pavlovic S, Mihaljevic B. “Prognostic Significance of Cereblon Expression in Patients With Multiple Myeloma.” Clin Lymphoma Myeloma Leuk. 2016 Nov;16(11):610-615.
  6. Karan-Djurasevic T, Palibrk V, Zukic B, Spasovski V, Glumac I, Colovic M, Colovic N, Jurisic V, Scorilas A, Pavlovic S, Tosic N. “Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers.” Med Oncol. 2013 Mar;30(1):405.
  7. Vucicevic K, Jakovljevic V, Colovic N, Tosic N, Kostic T, Glumac I, Pavlovic S, Karan-Djurasevic T, Colovic M. “Association of Bax Expression and Bcl2/Bax Ratio with Clinical and Molecular Prognostic Markers in Chronic Lymphocytic Leukemia.” J Med Biochem. 2016 Apr;35(2):150-157.

Please publish modules in offcanvas position.